GlassScriptPhysician profile
Nam D Tran
NPI 1780710418
$12,001.05
in general payments reported to CMS, 2019-2025
12 companies · $1,644 in 2025
The $1,644 reported for 2025 was more than what 93% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $450 · 2020: $54.46 · 2021: $162 · 2022: $571 · 2023: $108 · 2024: $9,011 · 2025: $1,644.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $7,448 · Travel and Lodging: $2,289 · Food and Beverage: $1,026.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $7,448.00 |
| Travel and Lodging | $2,288.95 |
| Food and Beverage | $1,026.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Roche Diagnostics International LTD | $8,623.07 | 2024-2025 | |
| Roche Molecular Systems, INC. | $1,148.07 | 2024 | |
| Emd Serono, INC. | $883.02 | 2019-2023 | |
| Coopersurgical, INC. | $752.63 | 2022-2025 | Stripper, Origio Sequential Fert, Kitazato Et Catheter |
| Impulse Dynamics (USA) INC. | $182.86 | 2024 | Optimizer |
| Stryker Corporation | $124.95 | 2024 | Sonopet Iq |
| Glaxosmithkline, LLC. | $121.82 | 2024 | Zejula |
| Ferring Pharmaceuticals INC. | $118.31 | 2019-2023 | Menopur |
| Roche Diagnostics Corporation | $31.10 | 2019 | |
| Organon LLC | $15.22 | 2024 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nam Tran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.